Evaluation of anti-IgE antibody therapy in the patients with wheat allergy
Not Applicable
- Conditions
- Wheat allergy
- Registration Number
- JPRN-UMIN000014272
- Lead Sponsor
- Shimane University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who had been administrated of Omalizumab in history, and patients who receive immunosuppressive drugs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the sensitization status before and after the therapy using basophil activation test, specific IgE test, and enzyme-linked immunosorbent assay.
- Secondary Outcome Measures
Name Time Method Food challenge test before and after the treatment if available.